• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices

  • Print
  • Share
  • E-mail

GRN No. 612

Fractionated whey protein isolate containing cows milk derived lactoferrin, lactoperoxidase, and transforming growth factor β2

Intended Use: For use as an ingredient in powdered, nonexempt term infant formulas and toddler formulas at levels up to 30 milligrams per 100 gram of powdered formula.
Basis: Scientific procedures
Notifier: Armor Protéines S.A.S
Notifier Address: 19 bis, rue de la Libération, 35460 Saint-Brice-en -Coglés, FRANCE
Date of filing: Dec 15, 2015
GRAS Notice (releasable information): GRN 612 (in PDF) (1.6 MB)
Date of closure: May 19, 2016
FDA's Letter: At the notifier's request, FDA ceased to evaluate this notice